2bo9: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
|PDB= 2bo9 |SIZE=350|CAPTION= <scene name='initialview01'>2bo9</scene>, resolution 1.60&Aring;
|PDB= 2bo9 |SIZE=350|CAPTION= <scene name='initialview01'>2bo9</scene>, resolution 1.60&Aring;
|SITE= <scene name='pdbsite=AC1:Acn+Binding+Site+For+Chain+L'>AC1</scene>
|SITE= <scene name='pdbsite=AC1:Acn+Binding+Site+For+Chain+L'>AC1</scene>
|LIGAND= <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>, <scene name='pdbligand=VAL:VALINE'>VAL</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene> and <scene name='pdbligand=ACN:ACETONE'>ACN</scene>
|LIGAND= <scene name='pdbligand=ACN:ACETONE'>ACN</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=VAL:VALINE'>VAL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>
|ACTIVITY=  
|ACTIVITY=  
|GENE=  
|GENE=  
|DOMAIN=
|RELATEDENTRY=
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2bo9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2bo9 OCA], [http://www.ebi.ac.uk/pdbsum/2bo9 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2bo9 RCSB]</span>
}}
}}


Line 29: Line 32:
[[Category: Vendrell, J.]]
[[Category: Vendrell, J.]]
[[Category: Ventura, S.]]
[[Category: Ventura, S.]]
[[Category: ACN]]
[[Category: MPD]]
[[Category: NAG]]
[[Category: VAL]]
[[Category: ZN]]
[[Category: endogenous protein inhibitor]]
[[Category: endogenous protein inhibitor]]
[[Category: hydrolase]]
[[Category: hydrolase]]
Line 41: Line 39:
[[Category: x-ray crystal structure]]
[[Category: x-ray crystal structure]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:04:30 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:09:17 2008''

Revision as of 02:09, 31 March 2008

File:2bo9.gif


PDB ID 2bo9

Drag the structure with the mouse to rotate
, resolution 1.60Å
Sites:
Ligands: , , , ,
Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH HUMAN LATEXIN.


OverviewOverview

The only endogenous protein inhibitor known for metallocarboxypeptidases (MCPs) is latexin, a 25-kDa protein discovered in the rat brain. Latexin, alias endogenous carboxypeptidase inhibitor, inhibits human CPA4 (hCPA4), whose expression is induced in prostate cancer cells after treatment with histone deacetylase inhibitors. hCPA4 is a member of the A/B subfamily of MCPs and displays the characteristic alpha/beta-hydrolase fold. Human latexin consists of two topologically equivalent subdomains, reminiscent of cystatins, consisting of an alpha-helix enveloped by a curved beta-sheet. These subdomains are packed against each other through the helices and linked by a connecting segment encompassing a third alpha-helix. The enzyme is bound at the interface of these subdomains. The complex occludes a large contact surface but makes rather few contacts, despite a nanomolar inhibition constant. This low specificity explains the flexibility of latexin in inhibiting all vertebrate A/B MCPs tested, even across species barriers. In contrast, modeling studies reveal why the N/E subfamily of MCPs and invertebrate A/B MCPs are not inhibited. Major differences in the loop segments shaping the border of the funnel-like access to the protease active site impede complex formation with latexin. Several sequences ascribable to diverse tissues and organs have been identified in vertebrate genomes as being highly similar to latexin. They are proposed to constitute the latexin family of potential inhibitors. Because they are ubiquitous, latexins could represent for vertebrate A/B MCPs the counterparts of tissue inhibitors of metalloproteases for matrix metalloproteinases.

About this StructureAbout this Structure

2BO9 is a Protein complex structure of sequences from Homo sapiens. This structure supersedes the now removed PDB entry 2BK7. Full crystallographic information is available from OCA.

ReferenceReference

Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin., Pallares I, Bonet R, Garcia-Castellanos R, Ventura S, Aviles FX, Vendrell J, Gomis-Ruth FX, Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3978-83. Epub 2005 Feb 28. PMID:15738388

Page seeded by OCA on Mon Mar 31 02:09:17 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA